Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI
- 31 December 2006
- journal article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 27 (4), 266-271
- https://doi.org/10.1016/j.jaut.2006.09.007
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antigenic structures recognized by anti-β2-glycoprotein I auto-antibodiesInternational Immunology, 2005
- Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic strokeRheumatology, 2005
- Advances in understanding what we measure when detecting anticardiolipin autoantibodiesClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemiaArquivos de Neuro-Psiquiatria, 2003
- Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid AutoantibodiesThe Journal of Immunology, 2002
- The Orientation of β2GPI on the Plate is Important for the Binding of Anti-β2GPI Autoantibodies by ELISAJournal of Autoimmunity, 2002
- β2-glycoprotein I–anti-β2-glycoprotein I InteractionJournal of Autoimmunity, 2000
- Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPIProceedings of the National Academy of Sciences of the United States of America, 1998
- Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Complete amino acid sequence of human plasma beta 2-glycoprotein I.Proceedings of the National Academy of Sciences of the United States of America, 1984